Non-invasive and tracheostomy invasive ventilation in amyotrophic lateral sclerosis: Utilization and survival rates in a cohort study over 12 years in Germany

被引:37
作者
Spittel, Susanne [1 ,2 ]
Maier, Andre [1 ]
Kettemann, Dagmar [1 ]
Walter, Bertram [1 ]
Koch, Birgit [1 ]
Krause, Kerstin [1 ]
Norden, Jenny [1 ]
Muench, Christoph [1 ,2 ]
Meyer, Thomas [1 ,2 ]
机构
[1] Charite Univ Med Berlin, Ctr ALS & Other Motor Neuron Disorders, Dept Neurol, Augustenburger Pl 1, D-13353 Berlin, Germany
[2] Ambulanzpartner Soziotechnol APST GmbH, Berlin, Germany
关键词
amyotrophic lateral sclerosis; invasive ventilation; non‐ survival; utilization rates; HOME MECHANICAL VENTILATION; LONG-TERM; NUTRITIONAL-STATUS; PROGNOSTIC-FACTORS; ALS; IMPACT; COMPLICATIONS; EPIDEMIOLOGY; PREDICTORS; TOLERANCE;
D O I
10.1111/ene.14647
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and purpose The aim of this study was to investigate utilization rates, treatment pathways and survival prognosis in patients with amyotrophic lateral sclerosis (ALS) undergoing non-invasive (NIV) and tracheostomy invasive ventilation (TIV) in a real-world setting. Methods A prospective cohort study using a single-centre register of 2702 ALS patients (2007 to 2019) was conducted. Utilization of NIV/TIV and survival data were analysed in three cohorts: (i) non-NIV; (ii) NIV (NIV without subsequent TIV); and (iii) TIV (including TIV preceded by NIV). Results A total of 1720 patients with available data were identified, 72.0% of whom (n = 1238) did not receive ventilation therapy. NIV was performed in 20.8% of patients (n = 358). TIV was performed in 9.5% of patients (n = 164), encompassing both primary TIV (7.2%, n = 124) and TIV with preceding NIV (2.3%, n = 40). TIV was more often utilized without previous NIV (25.7% vs. 8.3% of all ventilated patients), demonstrating that primary TIV was the prevailing pathway for invasive ventilation. The median (range) survival was significantly longer in the NIV cohort (40.8 [37.2-44.3] months) and the TIV cohort (82.1 [68.7-95.6] months) as compared to the non-NIV cohort (33.6 [31.6-35.7] months). Conclusions Although NIV represents the standard of care, its utilization rate was low. TIV was mainly started without preceding NIV, suggesting that TIV may not be confined to NIV treatment escalation. However, TIV was pursued in a minority of patients who had previously undergone NIV. The survival benefit observed in the patients with NIV was equal to that reported in a controlled pivotal trial, but the prognosis with TIV is highly variable. The determinants of utilization of NIV/TIV and of survival (bulbar syndrome, availability of ventilation-related home nursing, cultural factors) warrant further investigation.
引用
收藏
页码:1160 / 1171
页数:12
相关论文
共 47 条
  • [1] Ackermann H, 2012, LEITLINIEN DIAGNOSTI, V4, P205
  • [2] EFNS guidelines on the Clinical Management of Amyotrophic Lateral Sclerosis (MALS) - revised report of an EFNS task force
    Andersen, Peter M.
    Abrahams, Sharon
    Borasio, Gian D.
    de Carvalho, Mamede
    Chio, Adriano
    Van Damme, Philip
    Hardiman, Orla
    Kollewe, Katja
    Morrison, Karen E.
    Petri, Susanne
    Pradat, Pierre-Francois
    Silani, Vincenzo
    Tomik, Barbara
    Wasner, Maria
    Weber, Markus
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 (03) : 360 - E24
  • [3] Good practice in the management of amyotrophic lateral sclerosis: Clinical guidelines. An evidence-based review with good practice points. EALSC Working Group
    Andersen, Peter Munch
    Borasio, Gian Domenico
    Dengler, Reinhard
    Hardiman, Orla
    Kollewe, Katja
    Leigh, Peter Nigel
    Pradat, Pierre-Francois
    Silani, Vincenzo
    Tomik, Barbara
    [J]. AMYOTROPHIC LATERAL SCLEROSIS, 2007, 8 (04): : 195 - 213
  • [4] Identifying who will benefit from non-invasive ventilation in amyotrophic lateral sclerosis/motor neurone disease in a clinical cohort
    Berlowitz, David J.
    Howard, Mark E.
    Fiore, Julio F., Jr.
    Hoorn, Stephen Vander
    O'Donoghue, Fergal J.
    Westlake, Justine
    Smith, Anna
    Beer, Fiona
    Mathers, Susan
    Talman, Paul
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2016, 87 (03) : 280 - 286
  • [5] Discontinuation of mechanical ventilation in patients with amyotrophic lateral sclerosis
    Borasio, GD
    Voltz, R
    [J]. JOURNAL OF NEUROLOGY, 1998, 245 (11) : 717 - 722
  • [6] Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis
    Bourke, SC
    Tomlinson, M
    Williams, TL
    Bullock, RE
    Shaw, PJ
    Gibson, GJ
    [J]. LANCET NEUROLOGY, 2006, 5 (02) : 140 - 147
  • [7] El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis
    Brooks, BR
    Miller, RG
    Swash, M
    Munsat, TL
    [J]. AMYOTROPHIC LATERAL SCLEROSIS AND OTHER MOTOR NEURON DISORDERS, 2000, 1 (05): : 293 - 299
  • [8] Weaning from prolonged invasive ventilation in motor neuron disease: analysis of outcomes and survival
    Chadwick, R.
    Nadig, Vidya
    Oscroft, Nicholas S.
    Shneerson, John M.
    Smith, Ian E.
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2011, 82 (06) : 643 - 645
  • [9] Neurobehavioral dysfunction in ALS has a negative effect on outcome and use of PEG and NIV
    Chio, A.
    Ilardi, A.
    Cammarosano, S.
    Moglia, C.
    Montuschi, A.
    Calvo, A.
    [J]. NEUROLOGY, 2012, 78 (14) : 1085 - 1089
  • [10] Tracheostomy in amyotrophic lateral sclerosis: a 10-year population-based study in Italy
    Chio, A.
    Calvo, A.
    Ghiglione, P.
    Mazzini, L.
    Mutani, R.
    Mora, G.
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2010, 81 (10) : 1141 - 1143